欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4907/001
药品名称Fulvestrant
活性成分
    • Fulvestrant 50.0 mg/ml
剂型Solution for injection
上市许可持有人Medical Valley Invest AB Bradgardsvagen 28 Hollviken, Skane Lan, 236 32, Sweden
参考成员国 - 产品名称Netherlands (NL)
Fulvestrant Xiromed 250 mg oplossing voor injectie in een voorgevulde spuit
互认成员国 - 产品名称
    • Germany (DE)
      Fulvestrant AXiromed 250 mg Injektionslösung in Fertigspritzen
    • Denmark (DK)
    • Iceland (IS)
    • Spain (ES)
    • Sweden (SE)
    • Norway (NO)
      Fulvestrant Medical Valley
    • Poland (PL)
      Fulvestrant Medical Valley
许可日期2020/08/12
最近更新日期2025/04/23
药物ATC编码
    • L02BA03 fulvestrant
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase